ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $875 | -13.0% | 42 | 0.0% | 0.00% | – |
Q2 2023 | $1,006 | – | 42 | +110.0% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 20 | -77.5% | 0.00% | – |
Q2 2022 | $1,000 | -50.0% | 89 | -3.3% | 0.00% | – |
Q1 2022 | $2,000 | 0.0% | 92 | -8.0% | 0.00% | – |
Q4 2021 | $2,000 | -80.0% | 100 | -76.2% | 0.00% | – |
Q2 2021 | $10,000 | +150.0% | 420 | +172.7% | 0.00% | – |
Q1 2021 | $4,000 | +33.3% | 154 | +175.0% | 0.00% | – |
Q4 2020 | $3,000 | +50.0% | 56 | +33.3% | 0.00% | – |
Q2 2020 | $2,000 | – | 42 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |